IFO50276 A2058
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | IFO50276 | Cell Name | A2058 |
---|---|---|---|
Profile | malignant melanoma, metastasis to lymph node | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 43 |
Identity | available | Tissue for Primary Cancer | melanoma |
Case history | malignant melanoma | Metastasis | Yes |
Tissue Metastasized | lymph node | Genetics | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | malignant melanoma, metastasis to lymph node |
Classify | tumor | Established by | Fabricant, R. N. et al. |
Registered by | Kanamaru,T. | Regulation for Distribution | |
Comment | Year | 1990 | |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum | Methods for Passages | trypsin-EDTA |
Cell Number on Passage | Race | ||
CO2 Conc. | 5 % | Tissue Sampling | melanoma |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:3003087 | Laminin increases the release of type IV collagenase from malignant cells. Turpeenniemi-Hujanen T,Thorgeirsson UP,Rao CN,Liotta LA J Biol Chem. 1986 Feb 5;261(4):1883-9 |
Pubmed id:6933558 | Carbohydrate requirement for expression and stability of acetylcholine receptor on the surface of embryonic muscle cells in culture. Prives JM,Olden K Proc Natl Acad Sci U S A. 1980 Sep;77(9):5263-7 |
Pubmed id:286311 | Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Huberman E,Callaham MF Proc Natl Acad Sci U S A. 1979 Mar;76(3):1293-7 |
Pubmed id:265522 | Nerve growth factor receptors on human melanoma cells in culture. Fabricant RN,De Larco JE,Todaro GJ Proc Natl Acad Sci U S A. 1977 Feb;74(2):565-9 |
Images |
---|
LOT Information
Cell No. | IFO50276 | Cell Name | |
---|---|---|---|
LOT No. | 01282005 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS lot; GIBCO 3762782S) | Temperature | 37 C |
Cell Density at Seeding | 4 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | ca. 30 hrs | Cell Number in Vial (cells/1ml) | 3.3 x 10^6 |
Viability at cell freezing (%) | 97.9 | Antibiotics Used | free |
Passage Number | P17 at bank | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), AST, LD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50276 | Cell Name | A2058 |
---|---|---|---|
LOT No. | 1070 | Lot Specification | distribution |
Medium | D.MEM, 90% ; FBS, 10% | Temperature | 37 C |
Cell Density at Seeding | Methods for Passages | trypsin-EDTA | |
Doubling Time | Cell Number in Vial (cells/1ml) | 8 x 10^5 | |
Viability at cell freezing (%) | 93 | Antibiotics Used | free (previously treated with MC210, BM1, BM2) |
Passage Number | Unknown (13 at IFO) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NP, G6PD(type B), AST |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% serum (final conc.) - culture medium | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50276 | Cell Name | A2058 |
---|---|---|---|
LOT No. | 12252014 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091). Ampoule was mislabeled as A2059. Correctly, A2058. | Temperature | 37 C |
Cell Density at Seeding | approx. 4 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 40 hrs | Cell Number in Vial (cells/1ml) | 1.1 x 10^6 |
Viability at cell freezing (%) | 89 | Antibiotics Used | free |
Passage Number | Unknown (18 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:9,12 D13S317:13,14 D7S820:11 D16S539:9,13 VWA:14,18 TH01:7,9 AM:X,Y TPOX:8 CSF1PO:10,11 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 89 | Additional information | Ampoule was mislabeled as A2059. Correctly, A2058. |
Cell No. | IFO50276 | Cell Name | A2058 |
---|---|---|---|
LOT No. | 10202016 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 0.4 - 1.2 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 28 hrs. | Cell Number in Vial (cells/1ml) | 1.3 x 10^6 |
Viability at cell freezing (%) | 97 | Antibiotics Used | free |
Passage Number | Unknown (16 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 97 | Additional information |